Australia markets close in 5 hours 33 minutes

Fennec Pharmaceuticals Inc. (FENC)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
7.12-0.19 (-2.60%)
At close: 04:00PM EDT
7.02 -0.10 (-1.40%)
After hours: 04:23PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 190.77M
Enterprise value 170.96M
Trailing P/E 182.75
Forward P/E 8.31
PEG ratio (5-yr expected) N/A
Price/sales (ttm)4.51
Price/book (mrq)66.27
Enterprise value/revenue 3.80
Enterprise value/EBITDA 25.48

Trading information

Stock price history

Beta (5Y monthly) 0.46
52-week change 3-1.48%
S&P500 52-week change 328.04%
52-week high 311.92
52-week low 36.30
50-day moving average 39.79
200-day moving average 38.96

Share statistics

Avg vol (3-month) 3168.16k
Avg vol (10-day) 3317.63k
Shares outstanding 527.32M
Implied shares outstanding 637.02M
Float 815.38M
% held by insiders 114.49%
% held by institutions 152.73%
Shares short (30 Apr 2024) 41.81M
Short ratio (30 Apr 2024) 413.4
Short % of float (30 Apr 2024) 49.48%
Short % of shares outstanding (30 Apr 2024) 46.69%
Shares short (prior month 28 Mar 2024) 41.81M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 6.33%
Operating margin (ttm)54.15%

Management effectiveness

Return on assets (ttm)8.57%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)44.95M
Revenue per share (ttm)1.68
Quarterly revenue growth (yoy)1,413.20%
Gross profit (ttm)N/A
EBITDA N/A
Net income avi to common (ttm)2.84M
Diluted EPS (ttm)0.04
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)51.18M
Total cash per share (mrq)1.87
Total debt (mrq)31.37M
Total debt/equity (mrq)1,040.68%
Current ratio (mrq)6.93
Book value per share (mrq)0.11

Cash flow statement

Operating cash flow (ttm)27.48M
Levered free cash flow (ttm)-16.38k